[Role of statins in patients with acute coronary syndromes]. / La riduzione del rischio di nuovi eventi dopo sindrome coronarica acuta: qual è il ruolo delle statine?
G Ital Cardiol (Rome)
; 11(12 Suppl 3): 22S-26S, 2010 Dec.
Article
in It
| MEDLINE
| ID: mdl-21491736
ABSTRACT
After 10 years of studies on statins in acute coronary syndromes what have we learned? (1) The use of statins in acute coronary syndromes reduces coronary events during follow-up; (2) an "intensive" strategy based on the use of potent high dosage statins is effective on 4 to 6 months prognosis, nevertheless side effects and drug withdrawal are frequent; (3) beyond the usual paradigm "the lower the better", the new paradigm of "long term sustainability" should be developed, adopting adequate strategies; (4) a target-oriented study on statins in acute coronary syndrome is desirable, to evaluate which LDL values should be achieved or maintained for the best prognostic benefit.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Acute Coronary Syndrome
Type of study:
Prognostic_studies
Limits:
Humans
Language:
It
Journal:
G Ital Cardiol (Rome)
Journal subject:
CARDIOLOGIA
Year:
2010
Document type:
Article